1. Home
  2. ATOS vs ISTR Comparison

ATOS vs ISTR Comparison

Compare ATOS & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • ISTR
  • Stock Information
  • Founded
  • ATOS 2009
  • ISTR 2006
  • Country
  • ATOS United States
  • ISTR United States
  • Employees
  • ATOS N/A
  • ISTR N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • ISTR Major Banks
  • Sector
  • ATOS Health Care
  • ISTR Finance
  • Exchange
  • ATOS Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • ATOS 174.8M
  • ISTR 206.6M
  • IPO Year
  • ATOS 2012
  • ISTR 2014
  • Fundamental
  • Price
  • ATOS $1.54
  • ISTR $23.65
  • Analyst Decision
  • ATOS Strong Buy
  • ISTR
  • Analyst Count
  • ATOS 3
  • ISTR 0
  • Target Price
  • ATOS $6.25
  • ISTR N/A
  • AVG Volume (30 Days)
  • ATOS 502.2K
  • ISTR 38.1K
  • Earning Date
  • ATOS 11-19-2024
  • ISTR 10-21-2024
  • Dividend Yield
  • ATOS N/A
  • ISTR 1.77%
  • EPS Growth
  • ATOS N/A
  • ISTR N/A
  • EPS
  • ATOS N/A
  • ISTR 1.79
  • Revenue
  • ATOS N/A
  • ISTR $82,729,000.00
  • Revenue This Year
  • ATOS N/A
  • ISTR N/A
  • Revenue Next Year
  • ATOS N/A
  • ISTR $12.80
  • P/E Ratio
  • ATOS N/A
  • ISTR $12.93
  • Revenue Growth
  • ATOS N/A
  • ISTR N/A
  • 52 Week Low
  • ATOS $0.62
  • ISTR $9.83
  • 52 Week High
  • ATOS $2.31
  • ISTR $24.00
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 65.98
  • ISTR 72.64
  • Support Level
  • ATOS $1.36
  • ISTR $20.63
  • Resistance Level
  • ATOS $1.66
  • ISTR $24.00
  • Average True Range (ATR)
  • ATOS 0.07
  • ISTR 0.61
  • MACD
  • ATOS 0.02
  • ISTR 0.25
  • Stochastic Oscillator
  • ATOS 80.65
  • ISTR 94.87

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About ISTR Investar Holding Corporation

Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: